China's Mindray Slides From Weak Government Sales, Increasing Pressure From Multinational Competition

SHANGHAI - U.S.-listed Chinese medical device maker Mindray reported disappointing Q2 results, which made street analysts downgrade full year sales guidance for 2010 to around $700 million, which represents 10 percent growth compared to previous guidance of 17 percent